Cite

    Jackie Bloomer et al.. “Optimizing the in vitro and clinical assessment of drug interaction risk by understanding co-medications in patient populations.” Expert opinion on drug metabolism and toxicology, vol. 9, n.d., pp. 737–751. http://access.bl.uk/ark:/81055/vdc_100024527100.0x00004f